Your browser doesn't support javascript.
loading
Pharmacokinetics and Drug-Drug Interaction of Allisartan Isoproxil and Indapamide Sustained-Release Formulation.
Yi, Wu; Lin, Sisi; Hao, Rui; Shao, Yiming; Wang, Yannan; Yu, Jin; Fang, Lu; Zhu, Jingjing; Wang, Aiwei; Wu, Yanfang; Huang, Hua; Deng, Chongyang; Sun, Jingchao; Zhao, Hongcan; Wang, Ying; Tong, Xiangming.
Afiliación
  • Yi W; Department of Clinical Medicine, Medical College of Soochow University, Suzhou, China.
  • Lin S; Center for Clinical Pharmacy, Cancer Center, Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Hao R; Center for Clinical Pharmacy, Cancer Center, Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Shao Y; Center for Clinical Pharmacy, Cancer Center, Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Wang Y; Center for Clinical Pharmacy, Cancer Center, Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Yu J; Center for Clinical Pharmacy, Cancer Center, Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Fang L; Center for Clinical Pharmacy, Cancer Center, Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Zhu J; Center for Clinical Pharmacy, Cancer Center, Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Wang A; Center for Clinical Pharmacy, Cancer Center, Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Wu Y; Fuyang First People's Hospital, Hangzhou, Zhejiang, China.
  • Huang H; Fuyang First People's Hospital, Hangzhou, Zhejiang, China.
  • Deng C; Shenzhen Salubris Pharmaceuticals Co., Ltd, Shenzhen, China.
  • Sun J; Shenzhen Salubris Pharmaceuticals Co., Ltd, Shenzhen, China.
  • Zhao H; Shenzhen Salubris Pharmaceuticals Co., Ltd, Shenzhen, China.
  • Wang Y; Hangzhou First People's Hospital, Hangzhou, Zhejiang, China.
  • Tong X; Center for Clinical Pharmacy, Cancer Center, Clinical Research Institute, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Clin Pharmacol Drug Dev ; 12(11): 1051-1059, 2023 11.
Article en En | MEDLINE | ID: mdl-37814929
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipotensión / Indapamida Límite: Humans Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipotensión / Indapamida Límite: Humans Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos